Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus	Recruiting	Phase 1	2025-04-25		NCT06934447

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chongqing Precision Biotech Co., Ltd	34
The Children's Hospital of Zhejiang University School of Medicine	74

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
hildren's Hospital of Zhejiang University School of Medicine	Hangzhou	China	1

Clinical trials